Jiuzhitang Maker named to Huayi List's "Top 10 Most Promising Stem Cell Companies" list


来源:Jiuzhitang Maker named to Huayi List's "Top 10 Most Promising Stem Cell Companies" list

2023-12-11

On December 7-8, 2023, the highly anticipated "Huayi List · 2023 Cell and Gene Therapy Industry Visionary Ranking," initiated jointly by YiYun Technology, Pinhe Medical, and BioValley, was officially unveiled. Jiuzhitang Maker named to Huayi List's "Top 10 Most Promising Stem Cell Companies" ranking

Huayi Research Institute's growth-oriented criteria, developed over many years of accumulated experience Combining fundamental processes such as questionnaire surveys, interviews, data aggregation, and data verification, the evaluation is conducted across six key dimensions: competitive factors, value factors, strategic factors, product factors, team factors, and more. Leveraging dozens of quantitative assessment criteria, this comprehensive and in-depth analysis allows for a thorough evaluation of industries, sectors, and individual companies—ultimately identifying a select group of China’s top-performing, fastest-growing stem-cell enterprises. Creating an industry-wide, third-party, objective ranking list.

Being named among the "Top 10 Most Promising Stem Cell Companies" on the Huayi List is a testament to Jiuzhitang Maker's remarkable growth potential and robust capabilities in stem cell drug development—highly recognized and praised by industry experts. This achievement further strengthens Jiuzhitang Maker’s brand value in the rapidly evolving field of stem cell-based pharmaceutical innovation. Building on this milestone, Jiuzhitang Maker is committed to ramping up R&D investments, fostering continuous technological breakthroughs, refining operational efficiency, and expanding its clinical research pipeline for stem cells. Together, we’ll drive forward China’s biopharmaceutical innovation and industry growth, paving the way for a new chapter in stem cell and regenerative medicine research.